484 related articles for article (PubMed ID: 26041548)
1. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
[TBL] [Abstract][Full Text] [Related]
2. Impact of late toxicities on quality of life for survivors of nasopharyngeal carcinoma.
Tsai WL; Huang TL; Liao KC; Chuang HC; Lin YT; Lee TF; Huang HY; Fang FM
BMC Cancer; 2014 Nov; 14():856. PubMed ID: 25413127
[TBL] [Abstract][Full Text] [Related]
3. Intensity-modulated radiotherapy provides better quality of life than two-dimensional conventional radiotherapy for patients with stage II nasopharyngeal carcinoma.
Pan XB; Huang ST; Chen KH; Jiang YM; Ma JL; Qu S; Li L; Chen L; Zhu XD
Oncotarget; 2017 Jul; 8(28):46211-46218. PubMed ID: 28515352
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires.
Bian X; Song T; Wu S
Expert Rev Anticancer Ther; 2015 Jan; 15(1):109-19. PubMed ID: 25231774
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.
McDowell LJ; Rock K; Xu W; Chan B; Waldron J; Lu L; Ezzat S; Pothier D; Bernstein LJ; So N; Huang SH; Giuliani M; Hope A; O'Sullivan B; Bratman SV; Cho J; Kim J; Jang R; Bayley A; Ringash J
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):340-352. PubMed ID: 30191868
[TBL] [Abstract][Full Text] [Related]
6. Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy.
Huang TL; Tsai MH; Chuang HC; Chien CY; Lin YT; Tsai WL; Fang FM
Radiat Oncol; 2020 Apr; 15(1):84. PubMed ID: 32307024
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques.
Fang FM; Tsai WL; Chen HC; Hsu HC; Hsiung CY; Chien CY; Ko SF
Cancer; 2007 Jan; 109(2):313-21. PubMed ID: 17154159
[TBL] [Abstract][Full Text] [Related]
8. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study.
Fang FM; Chien CY; Tsai WL; Chen HC; Hsu HC; Lui CC; Huang TL; Huang HY
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):356-64. PubMed ID: 18355980
[TBL] [Abstract][Full Text] [Related]
9. Durability of the parotid-sparing effect of intensity-modulated radiotherapy (IMRT) in early stage nasopharyngeal carcinoma: A 15-year follow-up of a randomized prospective study of IMRT versus two-dimensional radiotherapy.
Poon DMC; Kam MKM; Johnson D; Mo F; Tong M; Chan ATC
Head Neck; 2021 Jun; 43(6):1711-1720. PubMed ID: 33576030
[TBL] [Abstract][Full Text] [Related]
10. Relationship Between the Comprehensive Nutritional Index and the EORTC QLQ-H&N35 in Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy.
He Y; Chen L; Chen L; Hu W; Wang C; Tang L; Mai H; Li J; Wu L; Fan Y
Nutr Cancer; 2017 Apr; 69(3):436-443. PubMed ID: 28287323
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment quality of life as a predictor of survival for patients with nasopharyngeal carcinoma treated with IMRT.
Guo SS; Hu W; Chen QY; Li JM; Zhu SH; He Y; Li JW; Xia L; Ji L; Lin CY; Liu LT; Tang LQ; Guo L; Mo HY; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Hong MH; Shao JY; Sun Y; Ma J; Fan YY; Mai HQ
BMC Cancer; 2018 Jan; 18(1):114. PubMed ID: 29386004
[TBL] [Abstract][Full Text] [Related]
12. Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: results of a prospective longitudinal study.
McMillan AS; Pow EH; Kwong DL; Wong MC; Sham JS; Leung LH; Leung WK
Head Neck; 2006 Aug; 28(8):712-22. PubMed ID: 16475203
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma.
Qiu WZ; Peng XS; Xia HQ; Huang PY; Guo X; Cao KJ
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1563-1572. PubMed ID: 28342002
[TBL] [Abstract][Full Text] [Related]
14. Late toxicity, evolving radiotherapy techniques, and quality of life in nasopharyngeal carcinoma.
Lastrucci L; Bertocci S; Bini V; Borghesi S; De Majo R; Rampini A; Pernici P; Gennari PG
Radiol Med; 2017 Apr; 122(4):303-308. PubMed ID: 28070838
[TBL] [Abstract][Full Text] [Related]
15. Concurrent chemoradiotherapy degrades the quality of life of patients with stage II nasopharyngeal carcinoma as compared to radiotherapy.
Pan XB; Huang ST; Chen KH; Jiang YM; Ma JL; Qu S; Li L; Chen L; Zhu XD
Oncotarget; 2017 Feb; 8(8):14029-14038. PubMed ID: 28152511
[TBL] [Abstract][Full Text] [Related]
16. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
Pow EH; Kwong DL; McMillan AS; Wong MC; Sham JS; Leung LH; Leung WK
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):981-91. PubMed ID: 17145528
[TBL] [Abstract][Full Text] [Related]
17. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.
Yang H; Hu W; Wang W; Chen P; Ding W; Luo W
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e47-54. PubMed ID: 23122981
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis.
Zhang B; Mo Z; Du W; Wang Y; Liu L; Wei Y
Oral Oncol; 2015 Nov; 51(11):1041-1046. PubMed ID: 26296274
[TBL] [Abstract][Full Text] [Related]
19. Evidence on effectiveness of intensity-modulated radiotherapy versus 2-dimensional radiotherapy in the treatment of nasopharyngeal carcinoma: Meta-analysis and a systematic review of the literature.
Co J; Mejia MB; Dizon JM
Head Neck; 2016 Apr; 38 Suppl 1():E2130-42. PubMed ID: 25546181
[TBL] [Abstract][Full Text] [Related]
20. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]